HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Subcutaneous immunoglobulin treatment of inclusion-body myositis stabilizes dysphagia.

AuthorsKaweh Pars, Niklas Garde, Thomas Skripuletz, Refik Pul, Reinhard Dengler, Martin Stangel
JournalMuscle & nerve (Muscle Nerve) Vol. 48 Issue 5 Pg. 838-9 (Nov 2013) ISSN: 1097-4598 [Electronic] United States
PMID23649689 (Publication Type: Letter)
Chemical References
  • Immunoglobulins
  • Immunoglobulins, Intravenous
Topics
  • Aged
  • Deglutition Disorders (etiology, immunology, therapy)
  • Humans
  • Immunoglobulins (administration & dosage)
  • Immunoglobulins, Intravenous (administration & dosage)
  • Injections, Intradermal (statistics & numerical data)
  • Male
  • Myositis, Inclusion Body (complications, immunology, therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: